» Articles » PMID: 36279944

Prevalence of Cardiovascular Diseases in COVID-19 Related Mortality in the United States

Overview
Date 2022 Oct 24
PMID 36279944
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several cardiovascular disease (CVD) risk factors and sequelae have been associated with COVID-19. Little is known about the distribution of CVD conditions in COVID-19 related deaths in the US population.

Methods: The public-use dataset by CDC, "Conditions Contributing to COVID-19 Deaths, by State and Age, Provisional 2020-2021", was abstracted as of August 1, 2021. A descriptive analysis was conducted to explore the overall and age-specific prevalence of various CVD and risk factors grouped by pre-specified ICD-10 codes amongst COVID-19 patient deaths. Respective trends over the duration of the pandemic were analyzed using the Mann-Kendall method, including time-periods before and after the introduction of vaccines in January 2021. All time-related analysis was conducted between March 2020 and June 2021.

Results: A total of 600,241 COVID-19 related deaths were reported between March 2020 and June 2021. Hypertensive diseases were the most prevalent (19.6%), followed by diabetes (15.9%), ischemic heart disease (IHD;10.9%), heart failure (7.7%), cardiac arrhythmias (7.5%), other diseases of the circulatory system (6.6%), cerebrovascular diseases (5%), and obesity (4.1%). While a significant downward trend was noted for hypertensive diseases over the course of the pandemic, cardiac arrhythmias, heart failure (HF), obesity, and other circulatory system diseases demonstrated a significant upward trend. Since the introduction of vaccines, the trends for heart failure and cardiac arrhythmias remained steady while having demonstrated a significant rise in the pre-vaccination time-period. While obesity and other diseases of the circulatory system predominated (>50%) amongst the CVD burden in the younger population (0-24 years and 25-34 years), the percentage occurrence of cardiac arrhythmias, hypertensive diseases, HF, and IHD increased with age.

Conclusion: Hypertensive diseases, diabetes, and IHD were the most prevalent cardiovascular conditions amongst COVID-19 related deaths. These patterns varied by age. While the trend for hypertensive diseases declined over the course of the pandemic, cardiac arrhythmias, HF, obesity, and other diseases of the circulatory system demonstrated an upward trend. An important limitation is the source of the data being limited to death certificates.

Citing Articles

Demographics and regional trends of ischemic heart disease-related mortality in older adults in the United States, 1999-2020.

Latif F, Moiz Nasir M, Rehman W, Hamza M, Mattumpuram J, Meer K PLoS One. 2025; 20(1):e0318073.

PMID: 39854527 PMC: 11760020. DOI: 10.1371/journal.pone.0318073.


Variation in the Impact of New York on Pause on Traffic Congestion by Racialized Economic Segregation and Environmental Burden.

Shearston J, Saxena R, Casey J, Kioumourtzoglou M, Hilpert M Geohealth. 2024; 8(12):e2024GH001050.

PMID: 39664924 PMC: 11632250. DOI: 10.1029/2024GH001050.


Comprehensive assessment of COVID-19 case fatality rate and influential factors in Khuzestan Province, Iran: a two-year study.

Bastani M, Makvandi M, Moradi M, Haghighi S, Rostami M, Nasimzadeh S J Health Popul Nutr. 2024; 43(1):193.

PMID: 39587667 PMC: 11587599. DOI: 10.1186/s41043-024-00673-6.


Geospatial analysis of cardiovascular mortality before and during the COVID-19 pandemic in Peru: analysis of the national death registry to support emergency management in Peru.

Moya-Salazar J, Marin E, Palomino-Leyva C, Rivera J, Torre R, Canari B Front Cardiovasc Med. 2024; 11:1316192.

PMID: 38887453 PMC: 11180746. DOI: 10.3389/fcvm.2024.1316192.


Genomic analysis of severe COVID-19 considering or not asthma comorbidity: GWAS insights from the BQC19 cohort.

Amri O, Madore A, Boucher-Lafleur A, Laprise C BMC Genomics. 2024; 25(1):482.

PMID: 38750426 PMC: 11097529. DOI: 10.1186/s12864-024-10342-x.


References
1.
Roth G, Johnson C, Abate K, Abd-Allah F, Ahmed M, Alam K . The Burden of Cardiovascular Diseases Among US States, 1990-2016. JAMA Cardiol. 2018; 3(5):375-389. PMC: 6145754. DOI: 10.1001/jamacardio.2018.0385. View

2.
Lippi G, Wong J, Henry B . Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020; 130(4):304-309. DOI: 10.20452/pamw.15272. View

3.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T . Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):811-818. PMC: 7101506. DOI: 10.1001/jamacardio.2020.1017. View

4.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

5.
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L . Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020; 109(5):531-538. PMC: 7087935. DOI: 10.1007/s00392-020-01626-9. View